Statements (44)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:drug
|
| gptkbp:bfsLayer |
6
|
| gptkbp:bfsParent |
gptkb:Bufo_alvarius
gptkb:N,_N-Dimethyltryptamine |
| gptkbp:affects |
euphoria
spiritual experiences altered perception of time intense visual and auditory hallucinations |
| gptkbp:composed_of |
can be synthesized chemically
|
| gptkbp:cultural_practices |
used in shamanic rituals
used in spiritual practices |
| gptkbp:duration |
30 to 60 minutes
|
| gptkbp:environmental_impact |
low
|
| gptkbp:historical_source |
plants
toad venom |
| https://www.w3.org/2000/01/rdf-schema#label |
5-Me O-DMT
|
| gptkbp:ingredients |
C13 H18 N2 O
|
| gptkbp:legal_issue |
varies by country
|
| gptkbp:manager |
smoking
insufflation |
| gptkbp:mass |
218.29 g/mol
|
| gptkbp:notable_users |
gptkb:musician
gptkb:Artist therapists spiritual seekers psychedelic researchers |
| gptkbp:premiered_on |
5 to 10 minutes when insufflated
immediate when smoked |
| gptkbp:previous_name |
N, N-Dimethyl-5-methoxytryptamine
|
| gptkbp:products |
gptkb:DMT
gptkb:bufotenin |
| gptkbp:research |
studied for therapeutic potential
studied for PTSD treatment studied for anxiety treatment studied for depression treatment |
| gptkbp:safety_features |
generally considered safe in controlled settings
|
| gptkbp:side_effect |
anxiety
dizziness nausea confusion increased heart rate |
| gptkbp:tradition |
rapid tolerance develops
|
| gptkbp:type_of |
1019-24-5
|
| gptkbp:year_created |
1936
|